This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Factors to Watch Ahead of The J.M. Smucker's (SJM) Q4 Earnings
by Zacks Equity Research
The J.M. Smucker's (SJM) fourth-quarter results are likely to reflect gains from pricing and core priorities amid cost inflation.
Reeds (REED) Reports Q1 Loss, Lags Revenue Estimates
by Zacks Equity Research
Reeds (REED) delivered earnings and revenue surprises of -66.67% and 20.98%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Campbell Soup (CPB) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Campbell (CPB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Smucker (SJM) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Smucker (SJM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
KHC vs. SJM: Which Stock Is the Better Value Option?
by Zacks Equity Research
KHC vs. SJM: Which Stock Is the Better Value Option?
Stryve Foods, Inc. (SNAX) Reports Q1 Loss, Lags Revenue Estimates
by Zacks Equity Research
Stryve Foods, Inc. (SNAX) delivered earnings and revenue surprises of 12.50% and 3.41%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
US Foods (USFD) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
US Foods (USFD) delivered earnings and revenue surprises of 31.58% and 0.28%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Hain Celestial (HAIN) Q3 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Hain Celestial (HAIN) delivered earnings and revenue surprises of -50% and 5.52%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Factors Likely to Influence Post Holdings' (POST) Q2 Earnings
by Zacks Equity Research
Post Holdings' (POST) second-quarter fiscal 2023 results are likely to reflect growth in the top and bottom lines owing to strength in its Foodservice segment.
Molson Coors (TAP) to Report Q1 Earnings: What's in Store?
by Zacks Equity Research
Molson Coors' (TAP) first-quarter results are expected to reflect the benefits of robust pricing actions, a revitalization plan and the premiumization of its global portfolio.
These 2 Consumer Staples Stocks Could Beat Earnings: Why They Should Be on Your Radar
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
The J. M. Smucker (SJM) Banks on Pricing Efforts & Strategies
by Zacks Equity Research
The J. M. Smucker (SJM) benefits from its positive net price realization across all segments. The company is also progressing well by focusing on its core strategies.
The J.M. Smucker (SJM) Q3 Earnings Beat, Sales Increase Y/Y
by Zacks Equity Research
The J.M. Smucker's (SJM) third-quarter fiscal 2023 results reflect higher sales on positive net price realization. However, earnings decline from the year-ago quarter's reported figure.
Smucker (SJM) Reports Q3 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
Although the revenue and EPS for Smucker (SJM) give a sense of how its business performed in the quarter ended January 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Smucker (SJM) Surpasses Q3 Earnings Estimates
by Zacks Equity Research
Smucker (SJM) delivered earnings and revenue surprises of 3.76% and 0.26%, respectively, for the quarter ended January 2023. Do the numbers hold clues to what lies ahead for the stock?
Should You Buy The J. M. Smucker (SJM) Ahead of Earnings?
by Zacks Equity Research
The J. M. Smucker (SJM) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
The J.M. Smucker (SJM) Readies for Q3 Earnings: Things to Note
by Zacks Equity Research
The J.M. Smucker's (SJM) third-quarter results are likely to reflect the adverse impacts of cost inflation, while pricing efforts and strength in the coffee business bode well.
Know What's in Store for Monster Beverage (MNST) in Q4 Earnings
by Zacks Equity Research
Monster Beverage (MNST) Q4 results are expected to reflect gains from strength in the energy drinks business, continued pricing actions to wean inflationary costs and product innovation.
B&G Foods (BGS) Readies for Q4 Earnings: Everything to Note
by Zacks Equity Research
B&G Foods' (BGS) fourth-quarter results are likely to reflect the adverse impacts of increased cost inflation, while pricing efforts bode well.
Here's How Freshpet (FRPT) Looks Just Ahead of Q4 Earnings
by Zacks Equity Research
Freshpet's (FRPT) fourth-quarter 2022 results are likely to reflect gains from the sturdy product offerings, innovation, pricing and distribution initiatives.
Smucker (SJM) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Smucker (SJM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why FEMSA (FMX) Looks Poised for an Earnings Beat in Q4
by Zacks Equity Research
FEMSA's (FMX) Q4 results are expected to reflect gains from strong demand, growth in the digital business and expansion into the specialized distribution industry.
Factors Likely to Influence Keurig's (KDP) Q4 Earnings
by Zacks Equity Research
A recovery in the coffee business and continued strength in Packaged Beverages are likely to have aided Keurig's (KDP) Q4 performance. Inflationary pressures are likely to have been concerning.
Things to Support Molson Coors' (TAP) Earnings Beat in Q4
by Zacks Equity Research
Molson Coors' (TAP) Q4 results are expected to reflect the benefits of pricing actions, the revitalization plan and the premiumization of its global portfolio.
Medifast (MED) Readies for Q4 Earnings: Everything to Note
by Zacks Equity Research
Medifast's (MED) fourth-quarter results are likely to reflect the adverse impacts of increased cost inflation, while strength in the OPTAVIA lifestyle solution and coaching support system bodes well.